Case report of mild form of a new coronavirus infection in patient with idiopathic pulmonary hypertension
https://doi.org/10.18087/cardio.2021.10.n1405
Abstract
The article presents a clinical case of mild novel coronavirus infection COVID-19 complicated with bilateral interstitial pneumonia in a female patient with idiopathic pulmonary hypertension.
Supporting agencies: No conflict of interest is reported.
About the Authors
S. E. Gratsianskaya
National medical research center of cardiology, Ministry of Healthcare, Moscow
Russian Federation
Russian Federation
Research assistant of the Department of pulmonary hypertension and heart disease
A. Yu. Demchenkova
National medical research center of cardiology, Ministry of Healthcare, Moscow
Russian Federation
Russian Federation
PhD, radiologist of the Department of tomography
T. V. Martynyuk
National medical research center of cardiology, Ministry of Healthcare, Moscow
Russian Federation
Russian Federation
Doctor of Medicine, Head of the Department of pulmonary hypertension and heart disease of Institute of Clinical Cardiology named after A.L. Myasnikov of National Medical Research Center of Cardiology
T. N. Veselova
National medical research center of cardiology, Ministry of Healthcare, Moscow
Russian Federation
Russian Federation
Doctor of Medicine, Senior researcher of the Department of tomography
S. K. Ternovoy
National medical research center of cardiology, Ministry of Healthcare, Moscow
Russian Federation
Russian Federation
Academician of Russian Academy of Science, professor, Doctor of Medicine, Chief Researcher of the Department of tomography of National Medical Research Center of Cardiology
References
1. Chazova I.E., Martynyuk T.V. Pulmonary hypertension. -M.: Praktika;2015. - 928 p. ISBN 978-5-89816-138-5
2. Ministry of Health of Russian Federation. Temporary methodical recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-2019). Version 8.0 (03.09.2020). Av. at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/777/original/030902020_COVID-19_v8.pdf. 2020.
3. Lee JD, Burger CD, Delossantos GB, Grinnan D, Ralph DD, Rayner SG et al. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care. Annals of the American Thoracic Society. 2020;17(12):1576–82. DOI: 10.1513/AnnalsATS.202005-521OC
4. Nuche J, Pérez-Olivares C, Segura de la Cal T, Jiménez LópezGuarch C, Arribas Ynsaurriaga F, Escribano Subías P. Clinical course of COVID-19 in pulmonary arterial hypertension patients. Revista Española de Cardiología (English Edition). 2020;73(9):775–8. DOI: 10.1016/j.rec.2020.05.015
5. Li B, Li X, Wang Y, Han Y, Wang Y, Wang C et al. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019. Emerging Microbes & Infections. 2020;9(1):787–93. DOI: 10.1080/22221751.2020.1750307
6. Hu L, Wang C. Radiological role in the detection, diagnosis and monitoring for the coronavirus disease 2019 (COVID-19). European Review for Medical and Pharmacological Sciences. 2020;24(8):4523–8. DOI: 10.26355/eurrev_202004_21035
7. Yang W, Sirajuddin A, Zhang X, Liu G, Teng Z, Zhao S et al. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). European Radiology. 2020;30(9):4874–82. DOI: 10.1007/s00330-020-06827-4
8. Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X et al. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. European Respiratory Journal. 2018;51(6):1702638. DOI: 10.1183/13993003.02638-2017
9. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nature Medicine. 2005;11(8):875–9. DOI: 10.1038/nm1267
10. Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323(22):2329. DOI: 10.1001/jama.2020.6825
11. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology. 2020;5(7):831–40. DOI: 10.1001/jamacardio.2020.1286
12. Wenzel RR, Rüthemann J, Bruck H, Schäfers RF, Michel MC, Philipp Th. Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man. British Journal of Clinical Pharmacology. 2001;52(2):151–7. DOI: 10.1046/j.0306-5251.2001.01422.x
13. Chen L, Liu P, Gao H, Sun B, Chao D, Wang F et al. Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome: A Rescue Trial in Beijing. Clinical Infectious Diseases. 2004;39(10):1531–5. DOI: 10.1086/425357
14. Farha S. COVID-19 and pulmonary hypertension. Cleveland Clinic Journal of Medicine. 2020;1–3. [Av. at: https://www.ccjm.org/content/ccjom/early/2020/05/12/ccjm.87a.ccc021.full.pdf]. DOI: 10.3949/ccjm.87a.ccc021
15. Martynyuk T.V., Aleevskaya A.M., Rodnenkov O.V., Zorin A.V., Kasparova A.M., Nakonechnikov S.N. et al. Management of patients with pulmonary arterial hypertension in the pandemic of a new coronavirus infection. Eurasian heart journal. 2020;2:54–60. DOI: 10.38109/2225-1685-2020-2-54-60
Review
For citations:
Gratsianskaya S.E., Demchenkova A.Yu., Martynyuk T.V., Veselova T.N., Ternovoy S.K. Case report of mild form of a new coronavirus infection in patient with idiopathic pulmonary hypertension. Kardiologiia. 2021;61(10):108-112. (In Russ.) https://doi.org/10.18087/cardio.2021.10.n1405
Views:
1132
Email this article 
Post a Comment 
